Indeed, blocking IL-13R or IL-13 itself with specific monoclonal antibodies (dupilumab, tralokinumab, lebrikizumab) is very effective in treating AD as well as in reducing pruritus [75]. Here, IL13 is linked to Alzheimer disease.